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In 1986, William Greenough and Janice Juraska edited a
volume entitled Developmental Neuropsychobiology. This
poly-syllabic title reflected a multi-disciplinary ambition.
As they noted in the introduction, “A motivating force
behind the organization of this book was our perception of
the mutual isolation of the fields of developmental
neuroscience and developmental psychobiology. Each has
its separate societies, journals, and international meetings,
and there is remarkably little overlap in membership and
even less in attendance at meetings” [9]. This was probably
not the first, and certainly not the last, well-intentioned
assault on the barriers between various neurodevelopmental
disciplines. Yet 23 years later we still lack a unified, inte-
grated science of the development of brain and behavior.
We have increasingly robust fields of developmental neuro-
science, developmental psychobiology, developmental psy-
chology and developmental psychopathology, but these
remain silos with their own professional societies, training
programs, and journals. This cultural balkanization is even
manifested in the languages used to describe developmental
processes: “epigenetics,”“ imprinting,” and “stress” have dif-
ferent meanings in these closely related disciplines. Beyond
the cultural separation, the lack of a unified science prevents
insights in one field from informing others, leaving all of us
with less understanding of development than might be
possible by combining diverse approaches.
The balkanization of disciplines is matched by a tendency
to study neurodevelopmental disorders in silos. With
Mendelian disorders, there is an argument for recognizing
the unique features of Fragile X or Turner’s Syndrome. But
much has been lost by not studying how these syndromes
overlap with a range of developmental disorders. We now
understand that defined genomic lesions can result in
heterogeneous phenotypes, but we need new insights into
the mechanisms by which the same apparent lesion, such as
the chromosome 1q21.1 deletion, leads to autism, mental
retardation, or microcephaly [12]. For non-Mendelian dis-
orders, such as autism, dyslexia, and neurotoxicologic devel-
opmental syndromes, the silo approach of research often fails
to capture the reality of the clinic, where children are more
likely to have many “disorders” rather than fit neatly into any
single category of the current diagnostic manual.
For many reasons the time has come to bring these dis-
parate fields together. As Freeman Dyson said of astronomy,
new tools are more likely to bring change than new concepts
[7]. Embryonic stem cells and induced pluripotent stem cells
can now be differentiated into specific families of neurons
[5]. These cells will open up reverse translational science:
moving from the clinic back to the lab to explore how
genetic variation leads to altered neural development. Whole
genome epigenomics promises to map the fingerprints of
experience during development, allowing a molecular under-
standing of how early experience can have enduring effects
on behavior [1]. And with cellular imaging we can watch
axons and dendrites find each other and follow changes in
synaptic density in real time in the whole organism [10].
Each of these tools—and there are many others—permits a
new approach to old problems by crossing the barriers from
molecular or cellular biology to behavior.
Beyond new tools, there is unprecedented excitement in
the study of neurodevelopmental disorders, especially
Mendelian disorders such as Fragile X syndrome, Rett
syndrome, and tuberous sclerosis [2, 3, 8]. For many
Mendelian neurodevelopmental disorders, transgenic ani-
mals manifest key features of the clinical syndrome. These
J Neurodevelop Disord (2009) 1:2–3
DOI 10.1007/s11689-009-9005-z
T. R. Insel (*)
NIMH/NIH,
Bethesda, MD 20892, USA
e-mail: insel@mail.nih.govexperimental model animals allow rigorous investigation of
how these disorders develop, identifying the earliest phases
of pathophysiology and, in some cases, revealing new
targets for treatment [4, 6, 13]. While this approach has not
yet proven itself for complex disorders, such as autism,
there is every reason to believe that rare, highly penetrant
mutations will be identified which can be studied in the
same way as causal mutations for Mendelian disorders.
The most compelling reason for an integrative approach to
neurobehavioral development is the public health mandate.
Mental disorders are increasingly recognized as the chronic
disorders of young people. These illnesses are common,
usually begin before age 25 [11], and are disabling for many
Americans. We recognize that many of these disorders, from
autism to attention deficit hyperactivity disorder to schizo-
phrenia, can be addressed as brain disorders. We understand
each of these illnesses as developmental disorders, or more
specifically as developmental brain disorders, resulting from
early alterations in brain development, whether the symp-
toms become manifest before age 3 (autism), during early
childhood (ADHD), before adolescence (anxiety disorders)
or during (or after) adolescence (schizophrenia, mood
disorders, and addictive disorders). The important insight to
inform a neurodevelopmental approach is that the behavioral
signs and symptoms are likely a late stage of the disorder. To
reduce the disability of these mental disorders, we will need
to detect them early and intervene before the behavioral
symptoms become manifest. This preemptive strategy has
transformed our approach to heart disease and cancer. For
preemptive medicine to transform our approach to mental
disorders, we will need a better understanding of the trajec-
tory of these illnesses as developmental brain disorders.
The need for a better understanding of normal and
atypical development in mental disorders brings us to the
great promise and the great challenge of this new journal,
Journal of Neurodevelopmental Disorders. With 5246
journals currently indexed in PubMed [14], one might ask
whether we need yet another journal. In this case, the
answer is a resounding “Yes,” especially if this new journal
can address the need for an integrative approach to both
normal and abnormal development. The challenge will be
to foster developmental science that crosses traditional
barriers between psychology and biology, between human
and non-human research, and between mechanistic and
descriptive studies. There has never been a better time for
this integration and never a greater need.
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